Presenting Author: L. Yesenia Rodriguez – ESSALUD
@@@ Héctor Garavito – ESSALUD ### 1360275###Co-Author######ESSALUD###Co-Author: Héctor Garavito – ESSALUD
@@@ Enrique Cachay – ESSALUD ### 1360276###Co-Author######ESSALUD###Co-Author: Enrique Cachay – ESSALUD
@@@ Gisela Alva – ESSALUD ### 1360277###Co-Author######ESSALUD###Co-Author: Gisela Alva – ESSALUD
@@@ Paola Fernández – ESSALUD ### 1360278###Co-Author######ESSALUD###Co-Author: Paola Fernández – ESSALUD
@@@ Tania Solis – ESSALUD ### 1360279###Co-Author######ESSALUD###Co-Author: Tania Solis – ESSALUD
@@@ Liz Veramendi – ESSALUD ### 1360280###Co-Author######ESSALUD###Co-Author: Liz Veramendi – ESSALUD
@@@ Juan Aldave – ESSALUD ### 1360281###Co-Author######ESSALUD###Co-Author: Juan Aldave – ESSALUD
@@@ Violeta Saromo – ESSALUD ### 1360282###Co-Author######ESSALUD###Co-Author: Violeta Saromo – ESSALUD
L-2DPresenting Author: Emily K. Acton – UPenn Center for Pharmacoepidemiology Research & Training
@@@ Sean Hennessy, PharmD, PhD, FISPE – UPenn Center for Pharmacoepidemiology Research & Training ### 1359957###Co-Author###Professor of Epidemiology and of Systems Pharmacology and Translational Therapeutics###UPenn Center for Pharmacoepidemiology Research & Training###Co-Author: Sean Hennessy, PharmD, PhD, FISPE – UPenn Center for Pharmacoepidemiology Research & Training
@@@ Colleen M. Brensinger, MS – Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US) ### 1357964###Co-Author######Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)###Co-Author: Colleen M. Brensinger, MS – Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)
@@@ Warren B. Bilker, PhD – University of Pennsylvania Perelman School of Medicine ### 1357965###Co-Author######University of Pennsylvania Perelman School of Medicine###Co-Author: Warren B. Bilker, PhD – University of Pennsylvania Perelman School of Medicine
@@@ Todd A. Miano, PharmD, PhD – Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US) ### 1357966###Co-Author######Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)###Co-Author: Todd A. Miano, PharmD, PhD – Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)
@@@ Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute ### 1062553###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###Co-Author: Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute
@@@ Allison W. Willis, MD, MS – Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US) ### 1358082###Co-Author######Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)###Co-Author: Allison W. Willis, MD, MS – Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania (Philadelphia, PA, US)
@@@ Charles E. Leonard, FISPE – University of Pennsylvania ### 1096939###Co-Author######University of Pennsylvania###Co-Author: Charles E. Leonard, FISPE – University of Pennsylvania
SP10BPresenting Author: Aleksi Hamina – University of Oslo
@@@ Ashley Muller – Institute of Public Health of Norway ### 1358120###Co-Author######Institute of Public Health of Norway###Co-Author: Ashley Muller – Institute of Public Health of Norway
@@@ Thomas Clausen, Prof. MD, PhD – University of Oslo ### 1358061###Co-Author######University of Oslo###Co-Author: Thomas Clausen, Prof. MD, PhD – University of Oslo
@@@ Svetlana Skurtveit – Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway ### 1358056###Co-Author######Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway###Co-Author: Svetlana Skurtveit – Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway
@@@ Morten Hesse – Aarhus University ### 1358121###Co-Author######Aarhus University###Co-Author: Morten Hesse – Aarhus University
@@@ Christian Tjagvad – University of Oslo ### 1358127###Co-Author######University of Oslo###Co-Author: Christian Tjagvad – University of Oslo
@@@ Birgitte Thylstrup – Aarhus University ### 1358122###Co-Author######Aarhus University###Co-Author: Birgitte Thylstrup – Aarhus University
@@@ Ingvild Odsbu – Karolinska Institutet ### 1358123###Co-Author###Researcher###Karolinska Institutet###Co-Author: Ingvild Odsbu – Karolinska Institutet
@@@ Helga Zoega – Centre for Big Data Research in Health, UNSW Sydney ### 1358124###Co-Author######Centre for Big Data Research in Health, UNSW Sydney###Co-Author: Helga Zoega – Centre for Big Data Research in Health, UNSW Sydney
@@@ Harpa Jónsdóttir – University of Iceland ### 1358125###Co-Author######University of Iceland###Co-Author: Harpa Jónsdóttir – University of Iceland
@@@ Heidi Taipale – Karolinska Institutet ### 1358126###Co-Author######Karolinska Institutet###Co-Author: Heidi Taipale – Karolinska Institutet
SP12CPresenting Author: Stephen S. Johnston – Johnson & Johnson
@@@ Luo Li – Johnson & Johnson ### 1360581###Co-Author######Johnson & Johnson###Co-Author: Luo Li – Johnson & Johnson
@@@ Harikumaran Dwarakanathan – Mu Sigma ### 1360582###Co-Author######Mu Sigma###Co-Author: Harikumaran Dwarakanathan – Mu Sigma
@@@ David Wei – Johnson & Johnson ### 1360583###Co-Author######Johnson & Johnson###Co-Author: David Wei – Johnson & Johnson
@@@ Pragya Rai – Johnson & Johnson ### 1360584###Co-Author######Johnson & Johnson###Co-Author: Pragya Rai – Johnson & Johnson
@@@ Paul Coplan, ScD, MBA, FISPE – Johnson & Johnson ### 1088172###Co-Author######Johnson & Johnson###Co-Author: Paul Coplan, ScD, MBA, FISPE – Johnson & Johnson
OP-20BPresenting Author: Amir Sarayani PharmD, MPH – University of Florida Department of Pharmaceutical Outcomes and Policy
@@@ Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida ### 1302738###Co-Author######Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida###Co-Author: Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida
@@@ Brian Cicali – Department of Pharmaceutics, University of Florida ### 1359280###Co-Author######Department of Pharmaceutics, University of Florida###Co-Author: Brian Cicali – Department of Pharmaceutics, University of Florida
@@@ Stephan Schmidt, PhD – Department of Pharmaceutics, University of Florida ### 1302737###Co-Author###Associate Professor, Director Center for Pharmacometrics and Systems Pharmacology###Department of Pharmaceutics, University of Florida###Co-Author: Stephan Schmidt, PhD – Department of Pharmaceutics, University of Florida
@@@ Joshua D Brown, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1302739###Co-Author###Assistant Professor###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###Co-Author: Joshua D Brown, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
SP10CModerator: Leah Sansbury – Ultragenyx Pharmaceuticals Inc
@@@ Patrice Verpillat ### 1409656###Moderator#########Moderator: Patrice Verpillat
Moderator: Edward Chia-Cheng Lai – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
@@@ Xabier Garcia de Albeniz – RTI Health Solutions ### 1062596###Moderator######RTI Health Solutions###Moderator: Xabier Garcia de Albeniz – RTI Health Solutions
Moderator: Charles E. Leonard, FISPE – University of Pennsylvania
@@@ Tobias Gerhard, PhD, FISPE – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1046831###Moderator######Rutgers Center for Pharmacoepidemiology and Treatment Science###Moderator: Tobias Gerhard, PhD, FISPE – Rutgers Center for Pharmacoepidemiology and Treatment Science
Moderator: Soko Setoguchi, MD, DrPH, FISPE – RWJ Medical School, Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Health Care Policy and Aging Research
@@@ Daniel Prieto-Alhambra – Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, United Kingdom ### 1062615###Moderator###Professor of Pharmaco- and Device Epidemiology###Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, United Kingdom###Moderator: Daniel Prieto-Alhambra – Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, United Kingdom
Moderator: Fredrik Nyberg, MPH, MD, PhD, FISPE – University of Gothenburg
@@@ Christopher T. Rentsch, MPH, PhD – London School of Hygiene and Tropical Medicine ### 1062599###Moderator######London School of Hygiene and Tropical Medicine###Moderator: Christopher T. Rentsch, MPH, PhD – London School of Hygiene and Tropical Medicine
Moderator: Chiduru Kobayashi – Shionogi & Co., Ltd.
@@@ Joan Forns, PhD – RTI Health Solutions ### 1062754###Moderator######RTI Health Solutions###Moderator: Joan Forns, PhD – RTI Health Solutions
Moderator: Emily S. Brouwer, MPH PharmD PhD – Janssen
@@@ Nicholas Everage ### 1409658###Moderator#########Moderator: Nicholas Everage
Moderator: Brett Hauber – University of Washington
@@@ Gita A. Toyserkani, PharmD, MBA – Division of Risk Management, FDA ### 1360117###Moderator###Associate Director, Research and Strategic Initiatives###Division of Risk Management, FDA###Moderator: Gita A. Toyserkani, PharmD, MBA – Division of Risk Management, FDA
Moderator: Rosa Gini – Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy
@@@ Judith C. Maro, PhD – Harvard Pilgrim Health Care Institute ### 1062626###Moderator######Harvard Pilgrim Health Care Institute###Moderator: Judith C. Maro, PhD – Harvard Pilgrim Health Care Institute
Moderator: M. Elle Saine, PhD,MA – Univeristy of Pennslyvania
@@@ Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine ### 1086987###Moderator###Professor###University of Missouri School of Medicine###Moderator: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine
Moderator: Chintan Dave – Rutgers Center for Pharmacoepidemiology and Treatment Science
@@@ Yola Moride – Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada ### 1062686###Moderator###Professor###Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada###Moderator: Yola Moride – Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada
Moderator: Stephen S. Johnston, PhD – Johnson & Johnson
@@@ Elaine H. Morrato, DrPH, MPH, CPH – Parkinson School of Public Health, Loyola University Chicago ### 1046822###Moderator###Professor and Founding Dean###Parkinson School of Public Health, Loyola University Chicago###Moderator: Elaine H. Morrato, DrPH, MPH, CPH – Parkinson School of Public Health, Loyola University Chicago
Moderator: Paul Coplan, ScD, MBA, FISPE – Johnson & Johnson
@@@ Nicole Pratt – University of South Australia ### 1358335###Moderator######University of South Australia###Moderator: Nicole Pratt – University of South Australia
Moderator: Jessica C. Young, PhD, MSPH – UNC Gillings School of Global Public Health
@@@ Eileen Ming ### 1409662###Moderator#########Moderator: Eileen Ming
Moderator: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University (SKKU)
@@@ Cynthia J. Girman, DrPH, FISPE – Patient Centered Outcomes Research Institute ### 1088317###Moderator###President###Patient Centered Outcomes Research Institute###Moderator: Cynthia J. Girman, DrPH, FISPE – Patient Centered Outcomes Research Institute
Moderator: Steven T. Bird, PhD, PharmD, MS – Division of Epidemiology, Office of Pharmacovigilance and Epidemiology, Food and Drug Administration
@@@ Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida ### 1302738###Moderator######Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida###Moderator: Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida
Moderator: Andrea V. Margulis, FISPE – RTI Health Solutions
@@@ Alexandra Z. Sosinsky – Harvard T.H. Chan School of Public Health ### 1084113###Moderator######Harvard T.H. Chan School of Public Health###Moderator: Alexandra Z. Sosinsky – Harvard T.H. Chan School of Public Health
Moderator: Christian Hampp, PhD – US Food and Drug Administration
@@@ Corinne de Vries ### 1409664###Moderator#########Moderator: Corinne de Vries
Moderator: Jennita Reefhuis, PhD – U.S. Centers for Disease Control and Prevention
@@@ Sandra Lopez – Novartis ### 1359005###Moderator######Novartis###Moderator: Sandra Lopez – Novartis
Moderator: Jesper Hallas, MD DMSc – University of Southern Denmark, Odense, Denmark
@@@ Francois-Xavier Lamy – UCB Biopharma, Belguim ### 1063061###Moderator######UCB Biopharma, Belguim###Moderator: Francois-Xavier Lamy – UCB Biopharma, Belguim
Moderator: Deborah Layton, Prof. Dr. – IQVIA Ltd.
@@@ Angela Lupattelli – Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1359947###Moderator######Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###Moderator: Angela Lupattelli – Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Moderator: Ursula Kirchmayer, n/a – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service
@@@ Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062592###Moderator###Associate Professor###Department of Epidemiology, University of North Carolina at Chapel Hill###Moderator: Jennifer L. Lund, PhD – Department of Epidemiology, University of North Carolina at Chapel Hill
Moderator: Montse Soriano Gabarro, MD, MSc, FISPE – Bayer AG
@@@ Jessica Jalbert, PhD – Regeneron Pharmaceuticals ### 1062874###Moderator######Regeneron Pharmaceuticals###Moderator: Jessica Jalbert, PhD – Regeneron Pharmaceuticals
Moderator: Jessica Franklin, PhD – Optum
@@@ Olaf H. Klungel – President, International Society for Pharmacoepidemiology ### 1062523###Moderator######President, International Society for Pharmacoepidemiology###Moderator: Olaf H. Klungel – President, International Society for Pharmacoepidemiology
Moderator: Joshua D Brown, PharmD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
@@@ Caitlin A. Knox, PhD,MPH – Regeneron Pharmaceuticals ### 1046818###Moderator###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###Moderator: Caitlin A. Knox, PhD,MPH – Regeneron Pharmaceuticals
Moderator: J Bradley Layton, PhD – RTI Health Solutions
@@@ Harry Seifert ### 1409666###Moderator#########Moderator: Harry Seifert
Moderator: Vera Ehrenstein, MPH, DSc – Department Of Clinical Epidemiology, Aarhus University, Aarhus, Denmark
@@@ Susana Perez-Gutthann – RTI Health Solutions, Barcelona, Spain ### 1061396###Moderator######RTI Health Solutions, Barcelona, Spain###Moderator: Susana Perez-Gutthann – RTI Health Solutions, Barcelona, Spain
Moderator: Susan dosReis, PhD – University of Maryland Baltimore, School of Pharmacy
@@@ Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics, Food and Drug Administration ### 1142411###Moderator###Team Leader, Science and Innovation Team###Office of Pediatric Therapeutics, Food and Drug Administration###Moderator: Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics, Food and Drug Administration
Moderator: Rachael L. DiSantostefano, PhD, MS – Johnson & Johnson
@@@ Mary Ritchey, MSPH, PhD, FISPE – Med Tech Epi, LLC ### 1046826###Moderator###Principal and Owner###Med Tech Epi, LLC###Moderator: Mary Ritchey, MSPH, PhD, FISPE – Med Tech Epi, LLC
PP-01Presenter: Joan Largent, MPH, PhD – IQVIA
@@@ Emily S. Brouwer, MPH PharmD PhD – Janssen ### 1360358###Presenter###Senior Director Immunology Epidemiology###Janssen###Presenter: Emily S. Brouwer, MPH PharmD PhD – Janssen
@@@ Cynthia J. Girman, DrPH, FISPE – Patient Centered Outcomes Research Institute ### 1088317###Presenter###President###Patient Centered Outcomes Research Institute###Presenter: Cynthia J. Girman, DrPH, FISPE – Patient Centered Outcomes Research Institute
@@@ Christen M. Gray, MPH, PhD – AstraZeneca ### 1360359###Presenter###Data Scientist###AstraZeneca###Presenter: Christen M. Gray, MPH, PhD – AstraZeneca
@@@ Michele Jonsson Funk – University of North Carolina at Chapel Hill ### 1046824###Presenter###Associate Professor###University of North Carolina at Chapel Hill###Presenter: Michele Jonsson Funk – University of North Carolina at Chapel Hill
@@@ Robert Glynn – Harvard T. H. Chan School of Public Health ### 1302713###Presenter###Professor of Medicine###Harvard T. H. Chan School of Public Health###Presenter: Robert Glynn – Harvard T. H. Chan School of Public Health
@@@ Dimitri Bennett – Takeda ### 1360360###Co-Author######Takeda###Co-Author: Dimitri Bennett – Takeda
@@@ Joshua Lin, MD ### 1082840###Co-Author#########Co-Author: Joshua Lin, MD
@@@ Daniela C. Moga, MD PhD – Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky ### 1358307###Co-Author######Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky###Co-Author: Daniela C. Moga, MD PhD – Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky
@@@ Sabina Nduaguba, PhD – University of Florida ### 1360361###Co-Author###Postdoctoral Associate###University of Florida###Co-Author: Sabina Nduaguba, PhD – University of Florida
@@@ Mary P. Prince Panaccio, BS, MS, PhD – Research Outcomes Innovations ### 1360362###Co-Author###President and Principal###Research Outcomes Innovations###Co-Author: Mary P. Prince Panaccio, BS, MS, PhD – Research Outcomes Innovations
@@@ Xuerong Wen – University of Rhode Island, College of Pharmacy ### 1062526###Co-Author######University of Rhode Island, College of Pharmacy###Co-Author: Xuerong Wen – University of Rhode Island, College of Pharmacy
@@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA ### 1360328###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
@@@ Hongbo Yuan, MD, MSc., Ph.D. – Canadian Agency for Drugs and Technologies in Health ### 1360363###Co-Author###Scientific Advisor###Canadian Agency for Drugs and Technologies in Health###Co-Author: Hongbo Yuan, MD, MSc., Ph.D. – Canadian Agency for Drugs and Technologies in Health
@@@ Huifeng Yun – Department of Epidemiology, University of Alabama at Birmingham ### 1063299###Co-Author###Associate professor###Department of Epidemiology, University of Alabama at Birmingham###Co-Author: Huifeng Yun – Department of Epidemiology, University of Alabama at Birmingham
WS-11Presenting Author: Asieh Golozar, MD, PhD, MHS, MPH – Regeneron Pharmaceuticals
@@@ Chieh-I Chen – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1358318###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Chieh-I Chen – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
@@@ Kathleen M. Aguilar – Ontada, The Woodlands, TX ### 1358319###Co-Author######Ontada, The Woodlands, TX###Co-Author: Kathleen M. Aguilar – Ontada, The Woodlands, TX
@@@ Kalatu Davies – Ontada, The Woodlands, TX ### 1358320###Co-Author######Ontada, The Woodlands, TX###Co-Author: Kalatu Davies – Ontada, The Woodlands, TX
@@@ Patrick R. LaFontaine – Sanofi, Cambridge, MA ### 1358411###Co-Author######Sanofi, Cambridge, MA###Co-Author: Patrick R. LaFontaine – Sanofi, Cambridge, MA
@@@ Matthew G. Fury – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1358322###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Matthew G. Fury – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
@@@ Timothy Bowler – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1358323###Co-Author######Regeneron Pharmaceuticals, Inc., Tarrytown, NY###Co-Author: Timothy Bowler – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
@@@ Jessica Jalbert, PhD – Regeneron Pharmaceuticals ### 1062874###Co-Author######Regeneron Pharmaceuticals###Co-Author: Jessica Jalbert, PhD – Regeneron Pharmaceuticals
@@@ C. Lance Cowey – Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX ### 1358317###Co-Author######Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX###Co-Author: C. Lance Cowey – Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
SP05APresenting Author: Mikhail Menis, PharmD – US Food and Drug Administration
@@@ Barbee I. Whitaker – FDA/CBER ### 1358509###Co-Author######FDA/CBER###Co-Author: Barbee I. Whitaker – FDA/CBER
@@@ Yixin Jiao – Acumen LLC ### 1358510###Co-Author######Acumen LLC###Co-Author: Yixin Jiao – Acumen LLC
@@@ An-Chi Lo – Acumen LLC ### 1358511###Co-Author######Acumen LLC###Co-Author: An-Chi Lo – Acumen LLC
@@@ Michael Wernecke – Acumen LLC ### 1358529###Co-Author######Acumen LLC###Co-Author: Michael Wernecke – Acumen LLC
@@@ Thomas E. MaCurdy – Acumen LLC ### 1358530###Co-Author######Acumen LLC###Co-Author: Thomas E. MaCurdy – Acumen LLC
@@@ Jeffrey A. Kelman – CMS ### 1358531###Co-Author######CMS###Co-Author: Jeffrey A. Kelman – CMS
@@@ Steven A. Anderson – FDA/CBER ### 1358532###Co-Author######FDA/CBER###Co-Author: Steven A. Anderson – FDA/CBER
@@@ Richard A. Forshee – FDA/CBER ### 1358508###Co-Author######FDA/CBER###Co-Author: Richard A. Forshee – FDA/CBER
SP03GPresenting Author: Silvia Perez-Vilar – US Food and Drug Administration
@@@ Ashley I. Martinez, PharmD, PhD – Harvard Pilgrim Health Care Institute ### 1358996###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute###Co-Author: Ashley I. Martinez, PharmD, PhD – Harvard Pilgrim Health Care Institute
@@@ Mayura Shinde, DrPH – Harvard Medical School ### 1358035###Co-Author######Harvard Medical School###Co-Author: Mayura Shinde, DrPH – Harvard Medical School
@@@ Maria E. Kempner, BA – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 1360312###Co-Author###Senior Research Analyst###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###Co-Author: Maria E. Kempner, BA – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
@@@ Joy Kolonoski – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 1358128###Co-Author######Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###Co-Author: Joy Kolonoski – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
@@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 1360313###Co-Author###Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
@@@ Brian Kit, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 1360314###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration###Co-Author: Brian Kit, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
L-1C